Apalutamide‐induced exanthematous drug eruption displaying spongiotic dermatitis successfully treated with dose reduction-Reference-Cited by-同舟云学术

Apalutamide‐induced exanthematous drug eruption displaying spongiotic dermatitis successfully treated with dose reduction

Published:2021-02-09 Issue:8 Volume:60 Page:
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Kawakami Yoshio¹,Mitsui Masao²,Takamoto Hitoshi²,Yamamoto Yasuo²

Affiliation:

1. Department of Dermatology Kurashiki Medical Center Kurashiki Japan

2. Department of Urology Kurashiki Medical Center Kurashiki Japan

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.15420

Reference5 articles.

1. Apalutamide for the treatment of prostate cancer

2. CTCAE v5.0; November 27 2017. Available from:https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf[Accessed September 10 2019].

3. A method for estimating the probability of adverse drug reactions

4. Enzalutamide and Apalutamide: In Vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model

5. Fatal case of toxic epidermal necrolysis due to apalutamide used as a novel prostate cancer drug

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations;Acta Dermato-Venereologica;2024-09-04

2. Case report: Apalutamide-induced severe lethal cutaneous adverse effects in China;Frontiers in Immunology;2024-01-11

3. Characteristics of mild and severe apalutamide‐related cutaneous adverse events in patients with prostate cancer: A review of the literature;The Journal of Dermatology;2023-09-21

4. Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer;Journal of Oncology Pharmacy Practice;2023-06-06

5. Acute generalized exanthematous pustulosis during apalutamide treatment in a patient with prostate cancer;IJU Case Reports;2022-08-16